Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Instituto Nacional de Diabetes y Enfermedades Digestivas y Renales Novo Nordisk
Tirzepatide SURMOUNT-1 (2022) and SURPASS-2 (2021) SURMOUNT-1 (Jastreboff et al., NEJM 2022): 2,539 non-diabetic adults with BMI 30, 72 weeks of tirzepatide 15 mg/week: Weight loss: 20.9% (vs 3.1% placebo) 91% of participants 5% loss, 56.7% 20% SURPASS-2 (Fras et al., NEJM 2021): 1,879 T2D patients head-to-head vs semaglutide 1 mg: HbA1c: 2.30% (tirzepatide 15 mg) vs 1.86% (semaglutide) Weight loss: 11.2 kg vs 5.7 kg Tirzepatide statistically outperforms semaglutide on both HbA1c and weight in a head-to-head trial a rare outcome in incretin pharmacology
3,4 Incretin-based therapies and SGLT-2 inhibitors have an ever- increasing emphasis within clinical guideline recommendations and are, therefore, increasingly utilized in clinical practice
Zinc is critical for testosterone synthesis
Whether you're exploring semaglutide in Stuart or TRT options, we are dedicated to supporting your weight loss journey, also serving clients in the Treasure Coast, FL
(2017) Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life Rubino, Francesco, et al
US$ 21.26
US$ 27.01
US$ 27.49
US$ 24.72
US$ 26.06
US$ 27.73
